Ads
-
Related paper
- NEUTROPHIL GELATINASE - ASSOCIATED LIPOCALIN (NGAL) IN RELATION TO RENAL ANEMIAOF HEMODIALYSIS PATIENTS
- Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Biomarker of Iron Deficiency in Hemodialysis Patients
- SERUM NEUTROPHIL GELATINASE - ASSOCIATED LIPOCALIN (NGAL) AS A MARKER OF TUBULOINTERSTITIAL DAMAGE IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
- Neutrophil Gelatinase Associated Lipocalin-Ngal: An Emerging Biomarker for Acute Kidney Injury
- Urine neutrophil gelatinase associated lipocalin (NGAL) in septic versus non-septic acute kidney injury
- Neutrophil Gelatinase-Associated Lipocalin (NGAL): A Promising Biomarker for Cancer Diagnosis and A Potential Target for Cancer Therapeutics
- Serum neutrophil gelatinase-associated lipocalin as an early biomarker of acute kidney injury in subjects undergoing percutaneous transluminal coronary angiogram with normal EGFR
- CLINICAL UTILITY OF URINE NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (UNGAL) AS A MARKER IN DISCRIMINATION OF SEPTIC VERSUS NON-SEPTIC ACUTE KIDNEY INJURY
- The Ratio of Dialysate NGAL to Plasm NGAL (NGAL D/P) Can Reflect Peritoneal Transport in CAPD Patients |Biomedgrid
- The use of epoetin alfa biosimilar in the anemia management in hemodialysis patients